GEODE CAPITAL MANAGEMENT, LLC
Position in DMAA — Drugs Made In America Acquisition Corp.
CIK 1214717
BOSTON, MA
Position in DMAA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$663,207
+$10,586 QoQ
Shares Held
62,273
0.0% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 23 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMAA Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $19,034,494 across 67 Shell Companies names. DMAA ranks #7 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VLOS |
Velos Acquisition I Corp.
|
89,720 | $971,667 | |
| 2 | KFII |
K&F Growth Acquisition Corp. II
|
83,571 | $881,674 | |
| 3 | NMP |
NMP Acquisition Corp.
|
82,066 | $841,997 | |
| 4 | CEPF |
Cantor Equity Partners IV, Inc.
|
79,015 | $821,756 | |
| 5 | SOCA |
Solarius Capital Acquisition Corp.
|
76,961 | $789,619 | |
| 6 | IPCX |
Inflection Point Acquisition Corp. III
|
67,978 | $702,212 | |
| 7 | DMAA |
Drugs Made In America Acquisition Corp.
This page
|
62,273 | $663,207 | |
| 8 | SPEG |
Silver Pegasus Acquisition Corp.
|
53,599 | $550,461 |
All Filings in DMAA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $663,207 | 62,273 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $652,621 | 62,273 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $473,552 | 45,648 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $468,804 | 45,648 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $465,609 | 45,648 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $455,529 | 45,462 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||